11/15
Public Health
Drug epidemic likely ‘killing more Americans than we think’
Research from Penn and Georgetown shows that the estimated number of drug-associated deaths in the U.S. in 2016 was approximately double the number of deaths attributed to drugs.
Direct-to-consumer fertility tests confuse and mislead consumers
Findings from the small, first-of-its-kind ethnographic study reinforce the need for consumer education around the purpose and accuracy of direct-to-consumer hormone-based fertility tests.
Philly water straight from the tap
A collaborative city-wide campaign that included ImpactED and the Water Center at Penn helped spread the word that Philadelphia tap water is safe and healthy to drink.
When automotive assembly plants close, deaths from opioid overdoses rise
A Penn study links eroding economic opportunity to opioid deaths, and builds on previous research that links declining participation in the labor force to increased opioid use in the U.S.
These overlooked global diseases take a turn under the microscope
Faculty at the School of Veterinary Medicine target neglected tropical diseases with advanced science, cross-disciplinary collaborations, and work in the lab and the field.
Without metrics, how do you rate drug treatment facilities?
With no national standard to measure drug treatment facilities, new research reveals opportunities to learn from patients to help create metrics.
Seven years later, PrEP access remains a challenge
Getting PrEP in the hands of high-risk communities remains a challenge; Penn researchers and practitioners are finding ways to reduce barriers and investigate new forms of the drug.
Using science to make cities safer and healthier
In a Q&A, criminologist John MacDonald discusses his new book, grounded in years of research on the positive effects of remediation like fixing up abandoned lots and houses.
How does opioid exposure affect brain development in young children?
That’s the question Allyson Mackey and Dylan Tisdall hope to answer, through a new grant from an NIH initiative focused on addiction research.
A novel approach to treating opioid use disorder
An FDA-approved drug called exendin-4 decreased voluntary oxycodone taking and drug-seeking behavior during withdrawal in rats without reducing the relief the opioid provided.
In the News
Got canker sores? Try switching your toothpaste
Richard Wender of the Perelman School of Medicine says that canker sores often start with a minor trauma to the mucosal lining, like a sharp edge on a tooth or a pair of prickly braces.
FULL STORY →
FDA Study finds infectious H5N1 bird flu virus in 14% of raw milk samples
Patrick E. Jamieson of the Annenberg Public Policy Center says it is important that anyone planning to consume raw milk be aware that doing so can make you sick and that pasteurization reduces the risk of milk-borne illnesses.
FULL STORY →
Colorado has the most cases of bird flu among dairy cows in the U.S.
The School of Veterinary Medicine has developed a bird flu vaccine that is to be tested by the U.S. Department of Agriculture.
FULL STORY →
This Juneteenth, we must invest in our future as well as remember our past
Victor Roy, an incoming assistant professor at the Perelman School of Medicine, writes that “baby bonds” could help mitigate the worsening racial wealth gap.
FULL STORY →
Column: How a blunder by a respected medical journal is fueling an anti-vaccine lie
Jeffrey S. Morris of the Perelman School of Medicine says that even with a 100% effective vaccine, there would have been high levels of morbidity and mortality from COVID-19 in 2021.
FULL STORY →
RFK Jr.’s vaccine misinformation campaign started after he ignored a Philly doctor
Paul Offit of the Perelman School of Medicine and Melanie Kornides of the School of Nursing comment on Robert F. Kennedy’s misinformation campaign against vaccines.
FULL STORY →